CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup

Background: Survival of metastatic colorectal cancer (mCRC) patients has improved, but mainly for trial patients. New predictive and prognostic biomarkers validated in the general mCRC population are needed. Caudal-type homeobox 2 (CDX2) is an intestine-specific transcription factor with potential p...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Front Oncol
Main Authors: Aasebø, Kristine, Dragomir, Anca, Sundström, Magnus, Mezheyeuski, Artur, Edqvist, Per-Henrik, Eide, Geir Egil, Ponten, Fredrik, Pfeiffer, Per, Glimelius, Bengt, Sorbye, Halfdan
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2020
Fag:
Oncology
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7026487/
https://ncbi.nlm.nih.gov/pubmed/32117703
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00008
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker